Skip to content

Left bundle branch area pacing in patients with new onset left bundle branch block and decreased left atrial global longitudinal strain induced by transcatheter aortic valve replacement

Left bundle branch area pacing in patients with new onset left bundle branch block and decreased left atrial global longitudinal strain induced by transcatheter aortic valve replacement

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100046992
Enrollment
Unknown
Registered
2021-06-06
Start date
2021-06-01
Completion date
Unknown
Last updated
2022-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic stenosis

Interventions

The experimental group:Left bundle branch area pacing and Guideline-guided medication
The control group:Guideline-guided medication

Sponsors

Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients after TAVR; 2. New left bundle branch block after surgery, lasting more than 3 months; 3. The absolute value of GLS in heart ultrasound was less than 20% in 3 months after operation; 4. Patients who can understand the purpose of the study, voluntarily participate in and sign an informed consent form, and are willing to accept relevant examinations and clinical follow-ups.

Exclusion criteria

Exclusion criteria: 1. Atrial fibrillation; 2. Past pacemaker implantation; 3. Pacemaker implantation is required due to atrioventricular block after operation; 4. Postoperative patients have been indicated for CRT implantation in accordance with the guidelines for heart failure; 5. Infective endocarditis during the active period or other infections considered by researchers to affect surgery; 6. Participated in other clinical trials in the last 3 months or are participating in other clinical trials; 7. Vulnerable groups, including people with mental illness, cognitive impairment, critically ill patients, minors, and pregnant women; 8. The researcher judges that the compliance is not good; 9. Any other circumstances that the investigator considers inappropriate to participate in the trial.

Design outcomes

Primary

MeasureTime frame
echocardiography results;N-terminal pro-brain natriuretic peptide;Heart function classification;

Countries

China

Contacts

Public ContactFu Guosheng

Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University

fugs@zju.edu.cn+86 13605800707

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026